Allergy Immunotherapy denied due to quantity / dose limits by Humana?
Quantity-limit denials usually flip when the appeal documents the clinically appropriate dose for the patient's weight, kidney function, or escalation schedule, citing the FDA label or specialty-society guideline.
US health-plan appeal rights
Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules
Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.
What Humana typically requires
Humana's specific coverage criteria for allergy immunotherapy are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.
The Humana angle on Allergy Immunotherapy
## Why Humana Limits Allergy Immunotherapy Quantities — and Why You Can Appeal
Allergen immunotherapy (allergy shots or sublingual drops) is a long-course treatment. Humana, like most major insurers, applies quantity-limit rules that restrict the number of vials, injections, or treatment sets dispensable within a defined period. These rules exist to manage utilization and prevent premature escalation, but they routinely conflict with the individualized, graduated dosing schedules that allergists build for each patient. When your prescribed protocol exceeds the plan's quantity ceiling, a denial is issued automatically — even if your allergist has documented compelling clinical reasons for the volume prescribed.
This denial is appealable. Quantity-limit determinations are coverage decisions, not final clinical judgments, and federal law gives you a structured path to challenge them.
## Your Federal Appeal Rights
- Internal appeal: ACA-compliant and ERISA plans must provide at least one level of internal review. You have the right to a full-and-fair review under ERISA §503, which requires the plan to explain every reason for denial and give you a chance to respond with evidence.
- External review: Under ACA §2719, if your internal appeal is denied you can request independent external review by an accredited Interrater Organization (IRO). The external reviewer is not employed by Humana and must apply recognized clinical standards. Most plans allow external review requests within approximately 180 days of the final internal denial — confirm the exact window in your denial letter.
- Expedited review: If your condition is urgent or a standard timeline would seriously jeopardize your health, request an expedited internal and/or external review. Decisions are typically required within 72 hours.
## Building Your Appeal: Documentation to Gather
1. Diagnosis confirmation — Allergy testing results (skin-prick or specific IgE) confirming the allergens being treated, with dates. 2. Prescriber's individualized treatment plan — The allergist's written protocol showing why the prescribed quantity is medically necessary for this patient's allergen panel, sensitivity pattern, and build-up phase. 3. Prior treatment history — Records of any prior immunotherapy courses, outcomes achieved, and the clinical rationale for the current volume. 4. Medical-necessity letter — A signed letter from your allergist explaining why the quantity limit does not fit your clinical situation and why reducing the volume would compromise safety or efficacy. 5. Applicable guideline reference — Your allergist should cite the relevant practice guideline organization (e.g., the American Academy of Allergy, Asthma & Immunology) to demonstrate that the prescribed protocol is consistent with accepted standards — without overstating specific numbers from those guidelines.
## Criteria-Mapping Strategy
Request Humana's current medical/coverage policy for allergy immunotherapy quantity limits. List every criterion the policy states. For each one, prepare a chart-based answer: the specific clinical finding, date it was recorded, and the treating physician who documented it. This side-by-side format shows the reviewer that every condition is met and that the quantity limit, as applied to your case, is inconsistent with your documented clinical needs.
Submit the appeal in writing, keep a copy of everything, and note the deadline from your denial letter. If Humana's internal reviewer upholds the denial, file for external review immediately.
Next steps
- Find the date on the denial letter — your appeal window starts there.
- Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
- Request the insurer's claim file in writing — they must provide it.
- Submit your appeal in writing with new clinical evidence and a physician statement.
Get the letter drafted
DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.
Start my appeal — $30 with code SEO25 →